Creating therapeutic cancer vaccines: notes from the battlefield
WW Overwijk, NP Restifo - Trends in immunology, 2001 - cell.com
Trends in immunology, 2001•cell.com
With the identification of tumor antigens and a knowledge of how to vaccinate against them,
the field of tumor immunology faces new challenges. In this article, the authors argue that
successful immunotherapies of the future will activate anti-tumor T cells without inducing
their anergy or apoptotic death.
the field of tumor immunology faces new challenges. In this article, the authors argue that
successful immunotherapies of the future will activate anti-tumor T cells without inducing
their anergy or apoptotic death.
Abstract
With the identification of tumor antigens and a knowledge of how to vaccinate against them, the field of tumor immunology faces new challenges. In this article, the authors argue that successful immunotherapies of the future will activate anti-tumor T cells without inducing their anergy or apoptotic death.
cell.com